{"id":5871,"date":"2025-05-14T15:00:00","date_gmt":"2025-05-14T15:00:00","guid":{"rendered":"https:\/\/weedman.ai\/?p=5871"},"modified":"2025-05-14T15:00:00","modified_gmt":"2025-05-14T15:00:00","slug":"oxford-cannabinoid-technologies-vstupuje-do-spravy-uprostred-biotechnologicke-krize","status":"publish","type":"post","link":"https:\/\/weedman.ai\/cs\/novinky\/prumysl\/2025\/05\/14\/oxford-cannabinoid-technologies-vstupuje-do-spravy-uprostred-biotechnologicke-krize\/","title":{"rendered":"Spole\u010dnost Oxford Cannabinoid Technologies vstoupila do spr\u00e1vy uprost\u0159ed biotechnologick\u00e9 krize"},"content":{"rendered":"<p>Spole\u010dnost Oxford Cannabinoid Technologies Holdings (OCTH), jedna z m\u00e1la farmaceutick\u00fdch firem zab\u00fdvaj\u00edc\u00edch se konop\u00edm ve Spojen\u00e9m kr\u00e1lovstv\u00ed, \u00fadajn\u011b vstoupila do nucen\u00e9 spr\u00e1vy. Spole\u010dnost, kter\u00e1 p\u016fsob\u00ed prost\u0159ednictv\u00edm sv\u00e9ho obchodn\u00edho subjektu Octavian Therapeutics, se p\u0159i financov\u00e1n\u00ed sv\u00fdch klinick\u00fdch zkou\u0161ek spol\u00e9hala p\u0159edev\u0161\u00edm na investice. A\u010dkoli spole\u010dnost OCTH ani jej\u00ed jmenovan\u00ed spr\u00e1vci, spole\u010dnost Rushtons Insolvency Limited, nevydali \u017e\u00e1dn\u00e9 ofici\u00e1ln\u00ed prohl\u00e1\u0161en\u00ed, \u010detn\u00e1 ve\u0159ejn\u00e1 pod\u00e1n\u00ed status spr\u00e1vy potvrzuj\u00ed.<\/p>\n\n\n\n<p>Spr\u00e1va spole\u010dnosti OCTH poukazuje na \u0161ir\u0161\u00ed krizi v celosv\u011btov\u00e9m biotechnologick\u00e9m pr\u016fmyslu, kter\u00e1 postihuje zejm\u00e9na americk\u00e9 spole\u010dnosti. Biotechnologick\u00fd sektor \u010del\u00ed rozs\u00e1hl\u00e9mu propou\u0161t\u011bn\u00ed a zpomalen\u00ed f\u00faz\u00ed a akvizic, p\u0159i\u010dem\u017e mo\u017enosti ve\u0159ejn\u00fdch investic do zna\u010dn\u00e9 m\u00edry ustaly. <\/p>\n\n\n\n<p>Dne 9. kv\u011btna 2025 bylo ve v\u011bstn\u00edku The Gazette, ofici\u00e1ln\u00edm z\u00e1znamu pro insolven\u010dn\u00ed \u0159\u00edzen\u00ed ve Spojen\u00e9m kr\u00e1lovstv\u00ed, zve\u0159ejn\u011bno jmenov\u00e1n\u00ed spr\u00e1vc\u016f spole\u010dnosti OCTH. Z pod\u00e1n\u00ed vypl\u00fdv\u00e1, \u017ee Nicola Bakerov\u00e1 ze spole\u010dnosti Rushtons Insolvency Limited p\u0159evzala funkci spr\u00e1vce dne 2. kv\u011btna 2025. Navzdory pokus\u016fm Business of Cannabis kontaktovat spole\u010dnost OCT a jej\u00edho poskytovatele komunika\u010dn\u00edch slu\u017eeb nebyly obdr\u017eeny \u017e\u00e1dn\u00e9 odpov\u011bdi. Prohl\u00e1\u0161en\u00ed spole\u010dnosti Dillistone Group Plc, k\u00f3tovan\u00e9 na burze AIM, v\u0161ak potvrdilo, \u017ee Julie Pomeroyov\u00e1, nev\u00fdkonn\u00e1 \u0159editelka OCTH, je informovala o spr\u00e1v\u011b spole\u010dnosti ve stejn\u00fd den.<\/p>\n\n\n\n<p>Budoucnost du\u0161evn\u00edho vlastnictv\u00ed OCT je nyn\u00ed nejist\u00e1. Hodnota OCT jako spole\u010dnosti, kter\u00e1 je\u0161t\u011b nedos\u00e1hla p\u0159\u00edjm\u016f, je odvozena p\u0159edev\u0161\u00edm z jej\u00edho du\u0161evn\u00edho vlastnictv\u00ed. K 30. \u010dervenci 2024 vlastnila spole\u010dnost OCT n\u011bkolik patent\u016f na sv\u00e9 hlavn\u00ed klinick\u00e9 aktivum, OCT461201, agonistu CB2 s malou molekulou zam\u011b\u0159en\u00e9ho na l\u00e9\u010dbu diabetick\u00e9 perifern\u00ed neuropatie, perifern\u00ed neuropatie vyvolan\u00e9 chemoterapi\u00ed a syndromu dr\u00e1\u017ediv\u00e9ho tra\u010dn\u00edku. Toto aktivum m\u011blo vstoupit do f\u00e1ze II klinick\u00fdch zkou\u0161ek v roce 2025 a bylo podpo\u0159eno osmi patenty pokr\u00fdvaj\u00edc\u00edmi trhy, jako jsou USA, Kanada a \u010c\u00edna. Spole\u010dnost OCT p\u0159edpokl\u00e1d\u00e1, \u017ee tr\u017en\u00ed potenci\u00e1l jej\u00edch l\u00e9k\u016f by mohl do roku 2030 p\u0159es\u00e1hnout $5,8 miliardy EUR.<\/p>\n\n\n\n<p>V \u00fanoru 2024 ocenila p\u0159edn\u00ed nez\u00e1visl\u00e1 v\u00fdzkumn\u00e1 spole\u010dnost Edison OCT na 25,3 milionu liber, co\u017e bylo v\u00fdrazn\u011b v\u00edce, ne\u017e byla jej\u00ed tehdej\u0161\u00ed tr\u017en\u00ed kapitalizace. Toto ocen\u011bn\u00ed bylo z velk\u00e9 \u010d\u00e1sti zalo\u017eeno na p\u0159edpokl\u00e1dan\u00e9m vstupu p\u0159\u00edpravku OCT461201 na trh v roce 2030, p\u0159i\u010dem\u017e dal\u0161\u00ed n\u00e1r\u016fst se o\u010dek\u00e1val od jeho druh\u00e9 slou\u010deniny OCT130401, kter\u00e1 je zam\u011b\u0159ena na neuralgii trigeminu.<\/p>\n\n\n\n<p>V roce 2021 si OCT zajistila exkluzivn\u00ed celosv\u011btovou licen\u010dn\u00ed smlouvu se spole\u010dnost\u00ed Canopy Growth Corporation, kter\u00e1 j\u00ed poskytuje pr\u00e1va na rozs\u00e1hlou knihovnu farmaceutick\u00fdch kanabinoidn\u00edch deriv\u00e1t\u016f. Tato knihovna p\u016fvodn\u011b obsahovala 335 deriv\u00e1t\u016f a souvisej\u00edc\u00ed pr\u00e1va du\u0161evn\u00edho vlastnictv\u00ed, kter\u00e1 se od t\u00e9 doby roz\u0161\u00ed\u0159ila na t\u00e9m\u011b\u0159 500 patentovan\u00fdch slou\u010denin. Potenci\u00e1ln\u00ed hodnota t\u011bchto aktiv je zna\u010dn\u00e1 v z\u00e1vislosti na tom, jak s nimi bude nakl\u00e1d\u00e1no po ukon\u010den\u00ed spr\u00e1vy spole\u010dnosti.<\/p>\n\n\n\n<p>P\u0159esto\u017ee OCT pod veden\u00edm Clarissy Sowemimo-Coker ud\u011blala velk\u00fd pokrok, \u010delila neust\u00e1l\u00fdm probl\u00e9m\u016fm s financov\u00e1n\u00edm, kter\u00e9 se je\u0161t\u011b zhor\u0161ily v d\u016fsledku zp\u0159\u00eds\u0148uj\u00edc\u00edho se finan\u010dn\u00edho prost\u0159ed\u00ed. V kv\u011btnu 2024 Sowemimo-Coker uvedla, \u017ee rozhodnut\u00ed spole\u010dnosti opustit ve\u0159ejn\u00fd trh m\u00e1 za c\u00edl vyu\u017e\u00edt v\u011bt\u0161\u00ed soukrom\u00e9 investi\u010dn\u00ed fondy. Jej\u00ed ned\u00e1vn\u00e1 kampa\u0148 na z\u00edsk\u00e1n\u00ed finan\u010dn\u00edch prost\u0159edk\u016f, jej\u00edm\u017e c\u00edlem bylo z\u00edskat 10 milion\u016f liber, v\u0161ak narazila na pot\u00ed\u017ee, pravd\u011bpodobn\u011b kv\u016fli v\u00e1havosti investor\u016f spojen\u00e9 s m\u011bn\u00edc\u00ed se politickou situac\u00ed a rozpo\u010dtov\u00fdmi \u0161krty v americk\u00fdch zdravotnick\u00fdch agentur\u00e1ch, kter\u00e9 vytvo\u0159ily probl\u00e9my pro biotechnologick\u00e9 spole\u010dnosti.<\/p>\n\n\n\n<p>Krach spole\u010dnosti OCTH p\u0159edstavuje v\u00fdznamnou ztr\u00e1tu jak pro farmaceutick\u00fd konopn\u00fd sektor, tak pro britsk\u00fd biotechnologick\u00fd pr\u016fmysl. Odr\u00e1\u017e\u00ed p\u0159etrv\u00e1vaj\u00edc\u00ed probl\u00e9my v odv\u011btv\u00ed, kter\u00e9 je zna\u010dn\u011b podfinancovan\u00e9, a poukazuje na rizika spojen\u00e1 s biotechnologick\u00fdm trhem, kde spole\u010dnosti \u010del\u00ed zv\u00fd\u0161en\u00fdm p\u0159ek\u00e1\u017ek\u00e1m p\u0159i zaji\u0161\u0165ov\u00e1n\u00ed investic a p\u0159i prov\u00e1d\u011bn\u00ed klinick\u00fdch zkou\u0161ek.<\/p>","protected":false},"excerpt":{"rendered":"<p>Spole\u010dnost Oxford Cannabinoid Technologies Holdings (OCTH), jedna z m\u00e1la farmaceutick\u00fdch firem zab\u00fdvaj\u00edc\u00edch se konop\u00edm ve Velk\u00e9 Brit\u00e1nii, \u00fadajn\u011b vstoupila do spr\u00e1vy.....<\/p>","protected":false},"author":2,"featured_media":5870,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[1970,1969,1971,1751],"class_list":["post-5871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-administration","tag-biotech","tag-intellectual-property","tag-investment"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oxford Cannabinoid Technologies enters administration amid biotech crisis - WeedMan<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/weedman.ai\/cs\/novinky\/prumysl\/2025\/05\/14\/oxford-cannabinoid-technologies-vstupuje-do-spravy-uprostred-biotechnologicke-krize\/\" \/>\n<meta property=\"og:locale\" content=\"cs_CZ\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oxford Cannabinoid Technologies enters administration amid biotech crisis - WeedMan\" \/>\n<meta property=\"og:description\" content=\"Oxford Cannabinoid Technologies Holdings (OCTH), one of the few pharmaceutical cannabis firms remaining in the UK, has reportedly entered administration.&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/weedman.ai\/cs\/novinky\/prumysl\/2025\/05\/14\/oxford-cannabinoid-technologies-vstupuje-do-spravy-uprostred-biotechnologicke-krize\/\" \/>\n<meta property=\"og:site_name\" content=\"WeedMan\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-14T15:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/05\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"WeedMan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napsal(a)\" \/>\n\t<meta name=\"twitter:data1\" content=\"WeedMan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Odhadovan\u00e1 doba \u010dten\u00ed\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuty\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/\"},\"author\":{\"name\":\"WeedMan\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/#\\\/schema\\\/person\\\/6dfcae95e60d21990500b72c7969aef0\"},\"headline\":\"Oxford Cannabinoid Technologies enters administration amid biotech crisis\",\"datePublished\":\"2025-05-14T15:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/\"},\"wordCount\":519,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/weedman.ai\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp\",\"keywords\":[\"administration\",\"biotech\",\"intellectual property\",\"investment\"],\"articleSection\":[\"Industry\"],\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/\",\"url\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/\",\"name\":\"Oxford Cannabinoid Technologies enters administration amid biotech crisis - WeedMan\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/weedman.ai\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp\",\"datePublished\":\"2025-05-14T15:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#breadcrumb\"},\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/weedman.ai\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp\",\"contentUrl\":\"https:\\\/\\\/weedman.ai\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp\",\"width\":2560,\"height\":1250,\"caption\":\"Credit: Business of Cannabis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/news\\\/industry\\\/2025\\\/05\\\/14\\\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/weedman.ai\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oxford Cannabinoid Technologies enters administration amid biotech crisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/#website\",\"url\":\"https:\\\/\\\/weedman.ai\\\/\",\"name\":\"WeedMan\",\"description\":\"Cannabis news, weed news, marijuana news\",\"publisher\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/weedman.ai\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"cs\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/#organization\",\"name\":\"WeedMan: cannabis news, insights and data\",\"url\":\"https:\\\/\\\/weedman.ai\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/weedman.ai\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-cropped-Screenshot-2025-03-19-at-19.45.36.png\",\"contentUrl\":\"https:\\\/\\\/weedman.ai\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-cropped-Screenshot-2025-03-19-at-19.45.36.png\",\"width\":696,\"height\":140,\"caption\":\"WeedMan: cannabis news, insights and data\"},\"image\":{\"@id\":\"https:\\\/\\\/weedman.ai\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/weedman.ai\\\/#\\\/schema\\\/person\\\/6dfcae95e60d21990500b72c7969aef0\",\"name\":\"WeedMan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/21627f0a0b88949cd87baec4fb27b612c3cc9b91b69280102e277660a75fae9c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/21627f0a0b88949cd87baec4fb27b612c3cc9b91b69280102e277660a75fae9c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/21627f0a0b88949cd87baec4fb27b612c3cc9b91b69280102e277660a75fae9c?s=96&d=mm&r=g\",\"caption\":\"WeedMan\"},\"url\":\"https:\\\/\\\/weedman.ai\\\/cs\\\/news\\\/author\\\/weedman\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oxford Cannabinoid Technologies vstupuje do spr\u00e1vy uprost\u0159ed biotechnologick\u00e9 krize - WeedMan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/weedman.ai\/cs\/novinky\/prumysl\/2025\/05\/14\/oxford-cannabinoid-technologies-vstupuje-do-spravy-uprostred-biotechnologicke-krize\/","og_locale":"cs_CZ","og_type":"article","og_title":"Oxford Cannabinoid Technologies enters administration amid biotech crisis - WeedMan","og_description":"Oxford Cannabinoid Technologies Holdings (OCTH), one of the few pharmaceutical cannabis firms remaining in the UK, has reportedly entered administration.&hellip;","og_url":"https:\/\/weedman.ai\/cs\/novinky\/prumysl\/2025\/05\/14\/oxford-cannabinoid-technologies-vstupuje-do-spravy-uprostred-biotechnologicke-krize\/","og_site_name":"WeedMan","article_published_time":"2025-05-14T15:00:00+00:00","og_image":[{"width":2560,"height":1250,"url":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/05\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp","type":"image\/webp"}],"author":"WeedMan","twitter_card":"summary_large_image","twitter_misc":{"Napsal(a)":"WeedMan","Odhadovan\u00e1 doba \u010dten\u00ed":"3 minuty"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#article","isPartOf":{"@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/"},"author":{"name":"WeedMan","@id":"https:\/\/weedman.ai\/#\/schema\/person\/6dfcae95e60d21990500b72c7969aef0"},"headline":"Oxford Cannabinoid Technologies enters administration amid biotech crisis","datePublished":"2025-05-14T15:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/"},"wordCount":519,"commentCount":0,"publisher":{"@id":"https:\/\/weedman.ai\/#organization"},"image":{"@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/05\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp","keywords":["administration","biotech","intellectual property","investment"],"articleSection":["Industry"],"inLanguage":"cs","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/","url":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/","name":"Oxford Cannabinoid Technologies vstupuje do spr\u00e1vy uprost\u0159ed biotechnologick\u00e9 krize - WeedMan","isPartOf":{"@id":"https:\/\/weedman.ai\/#website"},"primaryImageOfPage":{"@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#primaryimage"},"image":{"@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#primaryimage"},"thumbnailUrl":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/05\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp","datePublished":"2025-05-14T15:00:00+00:00","breadcrumb":{"@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#breadcrumb"},"inLanguage":"cs","potentialAction":[{"@type":"ReadAction","target":["https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/"]}]},{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#primaryimage","url":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/05\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp","contentUrl":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/05\/oxford-cannabinoid-technologies-enters-administration-amid-b.webp","width":2560,"height":1250,"caption":"Credit: Business of Cannabis"},{"@type":"BreadcrumbList","@id":"https:\/\/weedman.ai\/news\/industry\/2025\/05\/14\/oxford-cannabinoid-technologies-enters-administration-amid-biotech-crisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/weedman.ai\/"},{"@type":"ListItem","position":2,"name":"Oxford Cannabinoid Technologies enters administration amid biotech crisis"}]},{"@type":"WebSite","@id":"https:\/\/weedman.ai\/#website","url":"https:\/\/weedman.ai\/","name":"WeedMan","description":"Konopn\u00e9 novinky, novinky o tr\u00e1v\u011b, novinky o marihuan\u011b","publisher":{"@id":"https:\/\/weedman.ai\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/weedman.ai\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"cs"},{"@type":"Organization","@id":"https:\/\/weedman.ai\/#organization","name":"WeedMan: konopn\u00e9 zpr\u00e1vy, post\u0159ehy a data","url":"https:\/\/weedman.ai\/","logo":{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/weedman.ai\/#\/schema\/logo\/image\/","url":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/03\/cropped-cropped-Screenshot-2025-03-19-at-19.45.36.png","contentUrl":"https:\/\/weedman.ai\/wp-content\/uploads\/2025\/03\/cropped-cropped-Screenshot-2025-03-19-at-19.45.36.png","width":696,"height":140,"caption":"WeedMan: cannabis news, insights and data"},"image":{"@id":"https:\/\/weedman.ai\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/weedman.ai\/#\/schema\/person\/6dfcae95e60d21990500b72c7969aef0","name":"WeedMan","image":{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/secure.gravatar.com\/avatar\/21627f0a0b88949cd87baec4fb27b612c3cc9b91b69280102e277660a75fae9c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/21627f0a0b88949cd87baec4fb27b612c3cc9b91b69280102e277660a75fae9c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/21627f0a0b88949cd87baec4fb27b612c3cc9b91b69280102e277660a75fae9c?s=96&d=mm&r=g","caption":"WeedMan"},"url":"https:\/\/weedman.ai\/cs\/news\/author\/weedman\/"}]}},"_links":{"self":[{"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/posts\/5871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/comments?post=5871"}],"version-history":[{"count":1,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/posts\/5871\/revisions"}],"predecessor-version":[{"id":5925,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/posts\/5871\/revisions\/5925"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/media\/5870"}],"wp:attachment":[{"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/media?parent=5871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/categories?post=5871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/weedman.ai\/cs\/wp-json\/wp\/v2\/tags?post=5871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}